Showing 1 - 3 results of 3 for search 'Y. Elamin', query time: 0.01s
Refine Results
-
1
-
2
-
3
BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study by Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D.R. Spigel, D.S.W. Tan, A. Zalutskaya, F. Albayya, K.L. Reckamp
Published 2023-11-01Get full text
Article